NCT00000201
Completed
Phase 2
Pharmacological Modulation of Cocaine Effects
ConditionsCocaine-Related Disorders
DrugsSelegiline
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Cocaine-Related Disorders
- Sponsor
- National Institute on Drug Abuse (NIDA)
- Locations
- 1
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
The purpose of this study is to conduct human laboratory studies of possible cocaine interactions with various potential treatment medications.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 1
Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine - 1Cocaine-Related DisordersNCT00265265National Institute on Drug Abuse (NIDA)16
Completed
Phase 1
Study of Safety and Potential Efficacy of SYN117 in Cocaine Dependent VolunteersCocaine DependenceNCT00656357Biotie Therapies Inc.20
Terminated
Phase 1
Interactions Between Intravenous (IV) Cocaine and LofexidineCocaine Related DisordersNCT01148992National Institute on Drug Abuse (NIDA)16
Completed
Phase 1
Cocaine-Methylphendidate Interaction Study - 4Cocaine-Related DisordersNCT00015067National Institute on Drug Abuse (NIDA)8
Completed
Phase 1
Interactions Between Intravenous Cocaine and Acetazolamide or QuinineCocaine UsePharmacokineticsNCT01851473National Institute on Drug Abuse (NIDA)14